TABLE IV.
Variable | Comparator | For overall survival | For disease-free survival | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
||||||||
HR | 95.0% CI | p Valuea | HR | 95.0% CI | p Valuea | ||||
|
|
||||||||
Lower | Upper | Lower | Upper | ||||||
Age | <65 Years | 0.413 | 0.945 | ||||||
65–69 Years | 1.412 | 0.619 | 3.221 | 0.412 | 1.099 | 0.493 | 2.453 | 0.817 | |
≥70 Years | 1.660 | 0.763 | 3.611 | 0.201 | 0.939 | 0.429 | 2.055 | 0.876 | |
| |||||||||
Sex | |||||||||
Female | Male | 0.823 | 0.413 | 1.641 | 0.580 | 0.624 | 0.312 | 1.249 | 0.183 |
| |||||||||
ECOG PS | |||||||||
1–2 | 0 | 1.781 | 1.026 | 3.094 | 0.040 | 1.654 | 0.967 | 2.829 | 0.066 |
| |||||||||
T Stage | |||||||||
T3–4 | T2 | 2.088 | 1.015 | 4.297 | 0.046 | 1.481 | 0.756 | 2.902 | 0.252 |
| |||||||||
N Stage | |||||||||
N1–2 | N0 | 1.229 | 0.745 | 2.028 | 0.420 | 2.124 | 1.304 | 3.459 | 0.002 |
| |||||||||
Differentiation | Well differentiated | 0.690 | 0.919 | ||||||
Unknown | 0.544 | 0.157 | 1.889 | 0.338 | 0.747 | 0.246 | 2.266 | 0.606 | |
Poorly differentiated | 1.163 | 0.362 | 3.738 | 0.800 | 1.157 | 0.382 | 3.504 | 0.797 | |
Moderately well differentiated | 0.991 | 0.414 | 2.373 | 0.984 | 0.948 | 0.430 | 2.090 | 0.894 | |
| |||||||||
Neoadjuvant chemoradiation | |||||||||
Yes | No | 0.752 | 0.359 | 1.574 | 0.449 | 0.381 | 0.191 | 0.761 | 0.006 |
| |||||||||
Adjuvant chemotherapy | |||||||||
Yes | No | 0.321 | 0.157 | 0.656 | 0.002 | 0.379 | 0.187 | 0.769 | 0.007 |
Significant values shown in boldface type.